RecruitingNCT05907681

Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)


Sponsor

Samsung Medical Center

Enrollment

400 participants

Start Date

May 11, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.


Eligibility

Sex: FEMALEMin Age: 19 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This is an observational study (no experimental treatment is given) tracking the real-world outcomes of metastatic breast cancer patients who are receiving high-precision radiation therapy. The aim is to better understand how this type of radiation works in patients whose cancer has spread. **You may be eligible if...** - You have breast cancer that has spread to other parts of the body (metastatic) - You are receiving or planning to receive precision radiation therapy (IMRT, SBRT, or proton therapy) - You are willing and able to follow the study protocol **You may NOT be eligible if...** - You are unable to follow the study protocol Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Samsung Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05907681


Related Trials